Shoshana Golden’s Perspectives

55 total results. Page 1 of 5.

Alerts
Three Overhauls to Accelerated Drug Approval You Need to Know About: Novel Endpoints, Confirmatory Trials, and Expedited Withdrawal of Approvals
News
FDA Final Guidance on Cosmetic Facility Registration and Product Listing: Take Two
Health Care Counsel Blog
The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know
Investigations Blog
US Supreme Court Declines to Consider AKS ‘Willfulness’ Question
Investigations Blog
Florida Federal Judge Strikes Down FCA’s Qui Tam Provision as Unconstitutional
Alerts
New USDA Rules for FSIS-Regulated Products Aimed at Safeguarding Consumers
Health Care Counsel Blog
The 340B ‘Saga’ Continues: As More States Pass 340B Contract Pharmacy Laws, More Lawsuits Follow
Investigations Blog
Precision Lens Pays $12 Million to Resolve FCA and AKS Violations
Investigations Blog
Federal Court Dismisses $680 Million FCA Suit
Health Care Counsel Blog
The 2025 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know
Environmental Law Advisor
SCOTUS Update: Supreme Court Clarifies Organizational Standing in FDA-Related Ruling
Alerts
MoCRA Compliance: Key Legal Issues for Fashion Houses with Cosmetics